Patrick Nj Schnegelsberg - 28 Aug 2025 Form 3/A - Amendment Insider Report for Picard Medical, Inc. (PMI)

Role: Chief Executive Officer, Director
Signature: /s/ Emily Semon, as attorney-in-fact
Issuer symbol: PMI
Transactions as of: 28 Aug 2025
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 28 Aug 2025, 20:55:21 UTC
Date Of Original Report: 28 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SCHNEGELSBERG PATRICK NJ	Chief Executive Officer, Director	1992 E SILVERLAKE, TUCSON	/s/ Emily Semon, as attorney-in-fact	28 Aug 2025	0001360965

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PMI	Employee Stock Options (right to buy)							28 Aug 2025	Common Stock	2,378,124	$0.7100	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 28, 2024, the reporting person was granted 2,378,124 options, with a vesting commencement date of July 5, 2023. One quarter of the options cliff vested upon the first anniversary of the vesting commencement date, and the remaining options have vested or will vest ratably in equal monthly installments over the 36 months following the first anniversary of the vesting commencement date, generally subject to the continued service of the reporting person through each applicable vesting date.
F2	As adjusted to reflect the Company's 1 for 2.2 forward stock split of the Company's common stock and the Company's 1.0221 for 1 reverse stock split of the Company's common stock, resulting in an overall forward stock split of 1 for 2.1524.

Content

On June 28, 2024, the reporting person was granted 2,378,124 options, with a vesting commencement date of July 5, 2023. One quarter of the options cliff vested upon the first anniversary of the vesting commencement date, and the remaining options have vested or will vest ratably in equal monthly installments over the 36 months following the first anniversary of the vesting commencement date, generally subject to the continued service of the reporting person through each applicable vesting date.

As adjusted to reflect the Company's 1 for 2.2 forward stock split of the Company's common stock and the Company's 1.0221 for 1 reverse stock split of the Company's common stock, resulting in an overall forward stock split of 1 for 2.1524.

Remarks:

This Form 3/A is being filed to correct the conversion price to reflect the Company's 1 for 2.2 forward stock split of the Company's common stock and the Company's 1.0221 for 1 reverse stock split of the Company's common stock, resulting in an overall forward stock split of 1 for 2.1524.